Our proposed mechanism of AXIN2‐induced degradation of AXIN1 will correlate with the expression levels of AXIN2 and therefore will be most active in colorectal cancer cells expressing high AXIN2 levels [11]. The gene discussed is AXIN1; the disease is colorectal cancer.